Dr Jagtar Singh
Position:
- PhD , College of Health and Human Sciences, Charles darwin University, Charles Darwin University
Credentials:
- Master by Research at Charles Darwin University, Australia
- M.Sc.(Molecular Biology and Biochemistry) at Guru Nanak Dev University, Amristar, India
- B.Sc. (Biological Science) at Khalsa Collage, Amritsar, India
Websites:
Biography:
My main interests are in pathology, molecular biology and their use in understanding both the biology of cancer and in developing new techniques for cancer treatment and prevention. Moreover, my interest in investigating biomarkers in radiotherapy (RT) oncology to improve decision-making, treatment and therapy monitoring for prostate cancer patients. I have also interest to investigate blood (serum or plasma) and tumour tissue (Transrectal ultrasound (TRUS) guided tissue biopsies or prostatic needle biopsy specimens) of prostate cancer and head and neck squamous cell carcinoma for novel biomarkers (cytokines, P53 and eIF4E) and their association with RT-induced toxicity and cancer recurrence. I am highly motivated and hope to be able to pursue a successful life-long in cancer research.
Best publications:
PUBLICATIONS-
- Thomas M, Singh J, Lys I, Car G, Mileva M, Baxi S, et al. Identification of molecular and immunodiagnostic cancer markers in northern territory Australian indigenous population. Oral oncology 2011; 47, Supplement 1(0):S96.
- Thomas, M., Singh, J., Jayaraj, R. Head and Neck malignancy in Northern Territory. The Internet Journal of Head and Neck Surgery. 2011 Volume 4 Number 2.
- Singh, J., Jayaraj, R., Baxi, S., Curtin, J., Thomas, T. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol. Asian Pacific Journal of Cancer Prevention. 2013; Volume 14.
- Singh, J., Jayaraj, R., Baxi, S., Ramamoorthi, R., Thomas, T. Incidence and mortality from mucosal head and neck cancers amongst Australian States and Territories – what it means for the Northern Territory. Asian Pacific Journal of Cancer Prevention. 2013; Volume 14.
- Singh, J., Jayaraj, R., Baxi, S., Ramamoorthi, R., Thomas, T. The risk factors of head and neck cancer and their general patterns in Australia: a descriptive review and update. Journal of Environmental Pathology, Toxicology and Oncology. 2014; Volume 33.
- Jayaraj, R., Singh, J., Baxi, S., Ramamoorthi, R., Thomas, T. Trends in Incidence of Head and Neck Cancer in the Northern Territory, Australia, between 2007 and 2010. Asian Pacific Journal of Cancer Prevention. 2014; 15(18):7753-6.
- Singh, J., Jayaraj, R., Baxi, S., Mileva, M., Skinner, J., Dhand, N.S., Thomas, M. Immunohistochemical expression of p53 and eIF4E markers in histologically negative surgical margins and association with clinical outcome of head and neck squamous cell carcinoma (HNSCC) patients. Molecular and Clinical Oncology. DOI: 10.3892/mco.2015.689
- Singh J, Sohal SS, Lim A, Duncan H, Thachil T, De Ieso P. Cytokines expression levels from tissue, plasma or serum as promising clinical biomarkers in adenocarcinoma of the prostate: a systematic review of recent findings. Ann Transl Med 2019. doi: 10.21037/atm.2019.05.31
CONFERENCE ATTENDED-
- Singh J, Jayaraj R, Singh S.S, Loghides F, Lim A, Duncan H, Thachil T, De Ieso P. Analysis of Cytokine Expression in Prostate Cancer Patients Undergoing Radiation Therapy: Correlation with Clinicopathological Outcomes. Prostate Cancer Collaborative Research Symposium (PCCR 2015 Symposium), Nov 25-28, Brisbane.
- Singh J, Jayaraj R, Singh S.S, Loghides F, Lim A, Duncan H, Thachil T, De Ieso P. Analysis of Cytokine Expression in Prostate Cancer Patients Undergoing Radiation Therapy: Correlation with Clinicopathological Outcomes. Clinical Oncology Society of Australia (COSA 2015), 16th - 19th November 2015, Hobart, Tasmania (Poster Presentation)
Prostate Cancer, Cytokines, other biomarkers like P53 and eIF4E.
